Sfoglia per AUTORE
BERTOLI A
Collezione ASL Città di Torino

  

Items : 12

VIRONET-C real life experience of resistance-guided retreatment in HCV infected patients who previously failed a NS5A inhibitor-containing regimen in Digestive and Liver Disease

2020
ASL Città di Torino

Ceccherini-Silberstein F; Craxì A; Perno CF; Angelico M; Andreoni M; Zazzi M; Raimondo G; Puoti M; Gaeta GB; Baldanti F; Coppola N; Parruti G; Lampertico P; Ghisetti V; Beretta I; Cariti G; Rossetti B; Lleo A; Dentone C; Sighinolfi L; Giorgini A; Di Lorenzo F; Licata A; Mastroianni C; Milano E; Pellicelli A; Giannelli V; Rizzardini G; Ganga R; et alii...

Resistance-guided retreatment of HCV infected patients with a previous failure to an NS5A inhibitor-containing regimen: Italian real life experience in Journal of Hepatology

2019
ASL Città di Torino

Francesca Ceccherini S; Mario A; Federico Perno C; Andreoni M; Craxi A; Raimondo G; Zazzi M; Nicola C; Parruti G; Pellicelli A; Lampertico P; Rizzardini G; Ganga R; Puoti M; Paternoster C; Taliani G; Santantonio T; Babudieri S; De Santis A; Lichtner M; Cozzolongo R; Brunetto M; Borghi V; Rita Maida I; Morsica G; Sangiovanni V; Cuomo N; Ciancio A; Andreone P; et alii...

Resistance test guided retreatment of HCV infected patients with a previous failure to a NS5A inhibitor-containing regimen: the Italian Vironet C real life experience in Digestive and Liver Disease

2019
ASL Città di Torino

Ceccherini-Silberstein F; Perno CF; Craxì A; Angelico M; Andreoni M; Raimondo G; Zazzi M; Coppola N; Parruti G; Giorgini A; Lampertico P; Di Lorenzo F; Licata A; Mastroianni C; Milano E; Pellicelli A; Rizzardini G; Ganga R; Puoti M; Paternoster C; Santantonio T; Di Stefano M; Taliani G; Babudieri S; Lichtner M; De Santis A; Cozzolongo R; Colombatto P; Brunetto M; et alii...

Characterization of baseline factors associated with treatment outcome in HCV-infected patients naive to direct acting antivirals: particular focus on natural resistance in Digestive and Liver Disease

2019
ASL Città di Torino

Perno CF; Ceccherini-Silberstein F; Craxì A; Andreoni M; Baldanti F; Angelico M; Pasquazzi C; Parruti G; Lampertico P; Taliani G; Babudieri S; Rizzardini G; Pellicelli A; Puoti M; Paba P; Sarmati L; Borghi V; Lichtner M; Guarneri V; Siciliano M; Morisco F; Iapadre N; Maserati R; Bonora S; Micheli V; Boccaccio V; Galli S; Magni CF; Campoli R; et alii...

Evaluation of risk factors associated with failure to a first-line NS5A-containing regimen in HCV-infected patients naive to direct acting antivirals: Particular focus on natural resistance in Journal of Hepatology

2019
ASL Città di Torino

Silberstein FC; Perno CF; Mario A; Andreoni M; Parruti G; Pasquazzi C; Lampertico P; Taliani G; Rizzardini G; Babudieri S; Pellicelli A; Craxi A; Sarmati L; Puoti M; Paba P; Lichtner M; Andreone P; Siciliano M; Morisco F; Bonora S; Iapadre N; Maserati R; Boccaccio V; Micheli V; Galli S; Magni CF; Campoli R; Borghi V; Nicolini LA; et alii...

Evaluation of risk factors associated with failure to a first-line NS5A-containing regimen in HCV-infected patients naive to direct acting antivirals: Particular focus on natural resistance in Journal of Hepatology

2019
ASL Città di Torino

Ceccherini Silberstein F; Federico Perno C; Andreoni M; Mario A; Parruti G; Pasquazzi C; Lampertico P; Taliani G; Rizzardini G; Pellicelli A; Babudieri S; Craxi A; Puoti M; Sarmati L; Paba P; Lichtner M; Andreone P; Siciliano M; Morisco F; Iapadre N; Bonora S; Maserati R; Boccaccio V; Micheli V; Federico Magni C; Galli S; Campoli R; Borghi V; Ambra Nicolini L; et alii...

Decline of prevalence of resistance associated substitutions to NS3 and NS5A inhibitors at DAA failure in hepatitis C virus in Italy over the years 2015 to 2018 in Hepatology v70 suppl.1 2019

2019
ASL Città di Torino

Silberstein FC; Zazzi M; Craxì A; Federico Perno C; Angelico M; Andreoni M; Rizzardini G; Raimondo G; Battista Gaeta G; Lampertico P; Babudieri S; Caudai C; Cuomo N; Santantonio TA; Pollicino T; Brunetto MR; Andreone P; Borghi V; Aghemo A; Ciancio A; Cariti G; Giorgini A; Palitti VP; Ciaccio A; Licata A; Lenci I; Biolato M; Sangiovanni V; Prestileo T; et alii...

Italian real life experience of resistanceguided retreatment in HCV infected patients who previously failed a NS5A inhibitor-containing regimen in Hepatology v70 suppl.1 2019

2019
ASL Città di Torino

Silberstein FC; Perno CF; Craxì A; Angelico M; Andreoni M; Zazzi M; Raimondo G; Coppola N; Parruti G; Lampertico P; Beretta I; Rossetti B; Lleo A; Dentone C; Sighinolfi L; Di Lorenzo F; Giorgini A; Licata A; Mastroianni C; Milano E; Pellicelli A; Rizzardini G; Ganga R; Puoti M; Paternoster C; Di Stefano M; Santantonio TA; Taliani G; Biliotti E; et alii...

Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens? in Journal of hepatology / J Hepatol. 2018 Mar;68(3):597-600. doi: 10.1016/j.jhep.2017.09.008. Epub 2017 Sep 20.

2018
ASL Città di Torino

Ceccherini-Silberstein F; Baldanti F; Raimondo G; Perno CF; Barbaliscia S; Galli S; Gennari W; Zazzi M; Brunetto M; Bertoli A; Coppola N; Bruzzone B; Ghisetti V; Di Maio VC; Pollicino T; Paolucci S; Aragri M; Cento V;

Comparison of resistance profiles among DAA-naive and DAAexperienced patients infected with HCV non-1 genotype in Italy in Journal of Hepatology

2018
ASL Città di Torino

Silberstein FC; Cento V; Perno CF; Andreoni M; Angelico M; Sarmati L; Parruti G; Pasquazzi C; Craxi A; Gaeta GB; Raimondo G; Taliani G; Ciaccio A; Sangiovanni V; Rendina MG; Pellicelli A; Gubertini GA; Babudieri S; Bonora S; Boglione L; D'ambrosio R; Vullo V; Rossetti B; Zazzi M; Puoti M; Maserati R; Ciancio A; Boccaccio V; Lleo A; et alii...

Characterization of resistance profiles in HCV 2-3-4 DAA-naïve and DAA-experienced infected patients in Italy in Digestive and Liver Disease

2018
ASL Città di Torino

Ceccherini-Silberstein F; Perno CF; Cento V; Andreoni M; Angelico M; Parruti G; Sarmati L; Pasquazzi C; Craxì A; Gaeta GB; Raimondo G; Taliani G; Ciaccio A; Sangiovanni V; Pellicelli A; Rendina M; Gubertini G; Babudieri S; Bonora S; Boglione L; D'Ambrosio AR; Vullo V; Zazzi M; Rossetti B; Puoti M; Maserati R; Ciancio A; Boccaccio V; Lleo A; et alii...

Characteristic and prevalence of NS3, NS5A and NS5B resistance associated substitutions in DAA-naive and DAA-failed HCV-3 patients in italy in Hepatology

2017
ASL Città di Torino

Craxi A; Taliani G; Raimondo G; Ciaccio A; Sangiovanni V; Cariti G; Bonora S; Aghemo A; Vullo V; Foroghi L; Calvaruso V; Morisco F; Lleo A; Ciancio A; Maserati R; Brancaccio G; Puoti M; Toniutto P; Pollicino T; Paolucci S; Coppola N; Ruggiero T; Bruzzone B; Palitti VP; Gianserra L; Polilli E; Teti E; Lenci I; Aragri M; et alii...